Arrivent BioPharma, Inc. (AVBP)
13.68
+0.33
(+2.47%)
USD |
NASDAQ |
Nov 03, 11:43
Arrivent BioPharma Market Cap : 661.01M for Nov. 3, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 02, 2026 | 645.07M |
| October 30, 2026 | 718.51M |
| October 29, 2026 | 770.70M |
| October 28, 2026 | 760.07M |
| October 27, 2026 | 744.12M |
| October 26, 2026 | 742.19M |
| October 23, 2026 | 1.015B |
| October 22, 2026 | 927.74M |
| October 21, 2026 | 923.87M |
| October 20, 2026 | 910.82M |
| October 19, 2026 | 866.85M |
| October 16, 2026 | 805.00M |
| October 15, 2026 | 811.29M |
| October 14, 2026 | 782.78M |
| October 13, 2026 | 777.46M |
| October 12, 2026 | 795.34M |
| October 09, 2026 | 808.39M |
| October 08, 2026 | 807.42M |
| October 07, 2026 | 816.12M |
| October 06, 2026 | 729.14M |
| October 05, 2026 | 1.375B |
| October 02, 2026 | 1.366B |
| October 01, 2026 | 1.398B |
| September 30, 2026 | 1.463B |
| September 29, 2026 | 1.427B |
| Date | Value |
|---|---|
| September 28, 2026 | 1.416B |
| September 25, 2026 | 1.375B |
| September 24, 2026 | 1.454B |
| September 23, 2026 | 1.464B |
| September 22, 2026 | 1.465B |
| September 21, 2026 | 1.437B |
| September 18, 2026 | 1.396B |
| September 17, 2026 | 1.370B |
| September 16, 2026 | 1.336B |
| September 15, 2026 | 1.351B |
| September 14, 2026 | 1.380B |
| September 11, 2026 | 1.401B |
| September 10, 2026 | 1.387B |
| September 09, 2026 | 1.439B |
| September 08, 2026 | 1.463B |
| September 04, 2026 | 1.495B |
| September 03, 2026 | 1.499B |
| September 02, 2026 | 1.474B |
| September 01, 2026 | 1.457B |
| August 31, 2026 | 1.452B |
| August 28, 2026 | 1.458B |
| August 27, 2026 | 1.498B |
| August 26, 2026 | 1.505B |
| August 25, 2026 | 1.515B |
| August 24, 2026 | 1.366B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xencor, Inc. | 2.297B |
| NovaBridge Biosciences | 118.32M |
| ACADIA Pharmaceuticals, Inc. | 3.573B |
| Alnylam Pharmaceuticals, Inc. | 21.36B |
| Anika Therapeutics, Inc. | 257.89M |
Market Cap Related Metrics
| Price to Book Value | 1.802 |
| Price | 13.68 |
| Earnings Yield | -26.91% |